Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,764
Closed -$2.42M 69
2021
Q4
$2.42M Sell
10,764
-22,736
-68% -$4.8M 0.99% 33
2021
Q3
$7.12M Buy
33,500
+5,290
+19% +$1.22M 3.04% 10
2021
Q2
$6.88M Sell
28,210
-497
-2% -$122K 2.95% 10
2021
Q1
$6.6M Hold
28,707
3.46% 8
2020
Q4
$6.6M Buy
28,707
+4,244
+17% +$978K 3.46% 8
2020
Q3
$6.22M Buy
24,463
+1,083
+5% +$268K 3.74% 3
2020
Q2
$5.51M Buy
23,380
+299
+1% +$68.2K 3.38% 6
2020
Q1
$4.68M Buy
23,081
+4,895
+27% +$1.07M 3.38% 7
2019
Q4
$4.38M Buy
+18,186
New +$4.01M 2.69% 12
2019
Q3
Sell
-6,159
Closed -$1.14M 52
2019
Q2
$1.14M Buy
+6,159
New +$1.1M 0.85% 42
2018
Q2
Sell
-3,141
Closed -$540K 75
2018
Q1
$540K Sell
3,141
-2,118
-40% -$389K 0.38% 52
2017
Q4
$950K Buy
+5,259
New +$931K 0.67% 43

Other funds holding AMGN

Fluent Financial's AMGN Position: Q1 2022 in Review

Fluent Financial sold out of Amgen (AMGN) in Q1 2022, closing a stake of 10,764 shares — an estimated $2.42M sold.

Fluent Financial first reported a position in AMGN in Q4 2017 and held it in 12 quarters. The position peaked at $7.12M in Q3 2021. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Fluent Financial reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • Fluent Financial sold 10,764 Amgen shares in Q1 2022, an estimated $2.42M.
  • Fluent Financial first reported a position in Amgen in Q4 2017 and held it in 12 quarters.
  • Fluent Financial's Amgen position peaked at $7.12M in Q3 2021.
  • 2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Fluent Financial's 13F filing for Q1 2022, filed 10 May 2022.